139 related articles for article (PubMed ID: 3143879)
1. The depletion of rat cortical norepinephrine and the inhibition of [3H]norepinephrine uptake by xylamine does not require monoamine oxidase activity.
Dudley MW
Life Sci; 1988; 43(23):1871-7. PubMed ID: 3143879
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effect of xylamine on the uptake of [3H]norepinephrine into primary astrocyte cultures.
Chang TK; Cheng JT
Brain Res; 1992 Nov; 597(1):162-5. PubMed ID: 1477731
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effect of xylamine on the uptake of [3H]dopamine into isolated striatal synaptosomes of the rats.
Liang P; Chang SS; Cheng JT
Neurosci Lett; 1993 Apr; 153(2):181-4. PubMed ID: 8392155
[TBL] [Abstract][Full Text] [Related]
4. 2'-NH2-MPTP in Swiss Webster mice: evidence for long-term (6-month) depletions in cortical and hippocampal serotonin and norepinephrine, differential protection by selective uptake inhibitors or clorgyline and functional changes in central serotonin neurotransmission.
Andrews AM; Murphy DL
J Pharmacol Exp Ther; 1993 Dec; 267(3):1432-9. PubMed ID: 8263805
[TBL] [Abstract][Full Text] [Related]
5. Characterization of xylamine binding to proteins of PC12 pheochromocytoma cells.
Koide M; Cho AK; Howard BD
J Neurochem; 1986 Oct; 47(4):1277-85. PubMed ID: 3746302
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of rat brain cytosolic monoamine oxidase activity by clorgyline. Comparison with (-)-deprenyl and MDL 72145.
Azam M; Jain S; Baquer NZ
Biochem Pharmacol; 1990 Nov; 40(10):2215-8. PubMed ID: 2123104
[TBL] [Abstract][Full Text] [Related]
7. Tyramine-induced noradrenaline release from rat brain slices: prevention by (-)-deprenyl.
Glover V; Pycock CJ; Sandler M
Br J Pharmacol; 1983 Sep; 80(1):141-8. PubMed ID: 6418254
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of xylamine on extracellular concentrations of norepinephrine and dopamine in rat central nervous system: an in vivo electrochemical study.
Howard-Butcher S; Blaha CD; Lane RF
J Pharmacol Exp Ther; 1985 Apr; 233(1):58-63. PubMed ID: 3981462
[TBL] [Abstract][Full Text] [Related]
9. The effect of L-deprenyl, D-deprenyl and MDL72974 on mitochondrial respiration: a possible mechanism leading to an adaptive increase in superoxide dismutase activity.
Thiffault C; Quirion R; Poirier J
Brain Res Mol Brain Res; 1997 Oct; 49(1-2):127-36. PubMed ID: 9387872
[TBL] [Abstract][Full Text] [Related]
10. The effects of xylamine, a nitrogen mustard on [3H]norepinephrine accumulation in rabbit aorta.
Cho AK; Ransom RW; Fischer JB; Kammerer RC
J Pharmacol Exp Ther; 1980 Aug; 214(2):324-7. PubMed ID: 7391980
[TBL] [Abstract][Full Text] [Related]
11. Release of norepinephrine from organ-cultured superior cervical ganglia: effects of the norepinephrine uptake inhibitor xylamine.
Fischer JB; Cho AK
J Pharmacol Exp Ther; 1983 Jun; 225(3):623-9. PubMed ID: 6864523
[TBL] [Abstract][Full Text] [Related]
12. Effect of selective monoamine oxidase inhibition by clorgyline and deprenyl on the norepinephrine receptor-coupled adenylate cyclase system in rat cortex.
Mishra R; Gillespie DD; Youdim MB; Sulser F
Psychopharmacology (Berl); 1983; 81(3):220-3. PubMed ID: 6316394
[TBL] [Abstract][Full Text] [Related]
13. Effects of different monoamine oxidase inhibitors on the metabolism of L-dopa in the rat brain.
Nguyen TB; Angers M
Biochem Pharmacol; 1987 May; 36(10):1731-5. PubMed ID: 3109430
[TBL] [Abstract][Full Text] [Related]
14. Protection against DSP-4-induced neurotoxicity by deprenyl is not related to its inhibition of MAO B.
Finnegan KT; Skratt JJ; Irwin I; DeLanney LE; Langston JW
Eur J Pharmacol; 1990 Aug; 184(1):119-26. PubMed ID: 2120076
[TBL] [Abstract][Full Text] [Related]
15. Effect of long-term treatment with selective monoamine oxidase A and B inhibitors on dopamine release from rat striatum in vivo.
Lamensdorf I; Youdim MB; Finberg JP
J Neurochem; 1996 Oct; 67(4):1532-9. PubMed ID: 8858937
[TBL] [Abstract][Full Text] [Related]
16. Design and early clinical evaluation of selective inhibitors of monoamine oxidase.
Palfreyman MG; McDonald IA; Bey P; Schechter PJ; Sjoerdsma A
Prog Neuropsychopharmacol Biol Psychiatry; 1988; 12(6):967-87. PubMed ID: 3266532
[TBL] [Abstract][Full Text] [Related]
17. In vitro effects on monoamine uptake and release by the reversible monoamine oxidase-B inhibitors lazabemide and N-(2-aminoethyl)-p-chlorobenzamide: a comparison with L-deprenyl.
Bondiolotti GP; Galva MD; Villa F; Sciaba L; Picotti GB
Biochem Pharmacol; 1995 Jun; 50(1):97-102. PubMed ID: 7605351
[TBL] [Abstract][Full Text] [Related]
18. In vivo degradation of noradrenaline by MAO A in locus coeruleus of the rat.
Blinc M; Dernovsek M; Sket D
Experientia; 1989 Dec; 45(11-12):1099-102. PubMed ID: 2513220
[TBL] [Abstract][Full Text] [Related]
19. The monoamine oxidase B inhibitor deprenyl potentiates phenylethylamine behaviour in rats without inhibition of catecholamine metabolite formation.
Braestrup C; Andersen H; Randrup A
Eur J Pharmacol; 1975 Nov; 34(1):181-7. PubMed ID: 1241962
[TBL] [Abstract][Full Text] [Related]
20. Selective monoamine oxidase subtype inhibition and striatal extracellular dopamine in the guinea-pig.
Ilani T; Lamensdorf I; Finberg JP
Br J Pharmacol; 2000 Aug; 130(8):1992-8. PubMed ID: 10952692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
